Skip to ContentSkip to Navigation
How to find us prof. dr. W. (Wijnand) Helfrich


Synthesis and evaluation of 18F-enzalutamide, a new radioligand for PET Imaging of Androgen Receptors: A comparison with 16β-18F-fluoro-5α-dihydrotestosterone

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRP alpha "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation

Modular Medical Imaging Agents Based on Azide-Alkyne Huisgen Cycloadditions: Synthesis and Pre-Clinical Evaluation of(18)F-Labeled PSMA-Tracers for Prostate Cancer Imaging

A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

Development of Bispecific Antibody Derivatives for Cancer Immunotherapy

Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

Antigen-specific active immunotherapy for ovarian cancer

CD20-selective inhibition of CD47-SIRP alpha "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab

Read more